Melbourne researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.
Dr Ben Shields and Dr Matt McCormack from the Walter and Eliza Hall Institute’s Cancer and Haematology division discovered that loss of the Hhex protein put the handbrake on leukaemia cell growth and division. The protein is a critical factor enabling AML cells to grow uncontrollably, a hallmark of cancer.
AML is an aggressive blood cancer that appears suddenly, grows quickly and has a poor prognosis. Existing treatments for AML are associated with serious side-effects. About three quarters of patients relapse after only a short period of treatment, with a five-year survival rate of just 24 per cent.
Dr McCormack said discovering how AML overcame normal cellular controls on growth and division was a breakthrough in the search for new therapies.
“There is an urgent need for new therapies to treat AML,” said Dr McCormack. “We showed blocking the Hhex protein could put the brakes on leukaemia growth and completely eliminate AML in preclinical models. This could be targeted by new drugs to treat AML in humans.”
He said Hhex was a particularly attractive therapeutic target because it was overproduced in leukaemia and, while essential for leukaemia cell growth, was not needed by healthy blood cells.
“Most existing treatments for AML are not cancer cell-specific, and unfortunately kill off healthy cells in the process,” Dr McCormack said.
“Hhex is only essential for the leukaemic cells, meaning we could target and treat leukaemia without toxic effects on normal cells, avoiding many of the serious side-effects that come with standard cancer treatments. We also know that most people with AML have increased levels of Hhex, often associated with adverse outcomes, further indicating it is an important target for new AML drugs.”
Dr Shields said AML cells switched off the controls that strictly manage cell growth and division. “Every cell has control genes that are activated when a cell is stressed, such as in the early stages of cancer, and stop the damaged cell from reproducing.” Dr Shields said.
While these control genes are still present in AML cells, they are switched off through a process called epigenetic modification. “Hhex works by recruiting epigenetic factors to growth control genes, effectively silencing them. This allows the leukaemia cells to reproduce and accumulate more damage, contributing to the speed of AML progression,” Dr Shields said.
Dr McCormack said drugs that inhibit epigenetic modification had been previously used to treat AML, but caused significant toxicity because their targets were also required for normal blood cell function.
“Unlike the epigenetic factors targeted previously, Hhex only regulates a small number of genes and is dispensable for normal blood cells. This gives us a rare opportunity to kill AML cells without causing many side effects,” said Dr McCormack. “We now hope to identify the critical regions of the Hhex protein that enable it to function, which will allow us to design much-needed new drugs to treat AML.”
The Latest on: Leukaemia
via Google News
The Latest on: Leukaemia
- Roche announces Venclexta/Venclyxto combination improved overall survival in people with previously untreated acute myeloid leukaemiaon March 23, 2020 at 5:00 am
Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive leukaemia in adults live longer compared to azacitidine alone Data will be sha ...
- The five year old boy who fell of his bike and ended up with leukaemia diagnosison March 22, 2020 at 10:55 am
By taking the action to click anywhere on this page, or by clicking the “Continue to Site” button, you agree to allow us and various third parties to store and access cookies on your device for MSN ...
- Snooker legend Willie Thorne stuck in a Spanish hospital as he battles leukaemiaon March 21, 2020 at 3:30 pm
Willie Thorne is facing the biggest fight of his life after the former snooker star and popular entertainer was diagnosed with leukaemia. He is locked in a room on his own in a Spanish hospital and, ...
- Evangeline Lilly refuses to self-quarantine – she lives with her dad who has leukaemiaon March 19, 2020 at 8:39 pm
The MCU and Lost actress also shared that she was still sending her kids to participate in activities despite warnings from health officials to practise social distancing. A ctress Evangeline Lilly ...
- Willie Thorne: Snooker legend diagnosed with leukaemiaon March 18, 2020 at 9:27 pm
Snooker legend Willie Thorne has been left ‘devastated’ after being diagnosed with leukaemia. The 66-year-old broadcaster - who reached the World Championship quarter-finals in 1986 - revealed on ...
- Former snooker player and commentator Willie Thorne diagnosed with leukaemiaon March 18, 2020 at 3:58 pm
Former snooker star and broadcaster Willie Thorne has said he has been diagnosed with leukaemia. The 66-year-old - who reached the World Championship quarter-finals in 1986 - revealed on Twitter that ...
- Willie Thorne to undergo chemotherapy treatment for leukaemiaon March 18, 2020 at 12:59 pm
Willie Thorne began his professional snooker career in 1975, reaching a career-high world ranking of seven in 1987 and 1994 Willie Thorne, one of snooker's most popular figures, is to undergo ...
- Willie Thorne diagnosed with leukaemiaon March 18, 2020 at 12:57 pm
Former snooker star and broadcaster Willie Thorne has said he has been diagnosed with leukaemia. The 66-year-old – who reached the World Championship quarter-finals in 1986 – revealed on Twitter that ...
- Willie Thorne, ex-snooker star and BBC commentator reveals he has leukaemiaon March 18, 2020 at 9:38 am
Former snooker player and BBC commentator Willie Thorne has revealed he is fighting leukaemia. The 66-year-old, who played snooker professionally for over 25 years and was a voice of the sport on ...
- Willie Thorne diagnosed with leukaemia aged 66 as ‘devastated’ snooker legend says he is starting chemotherapy in Spainon March 18, 2020 at 9:22 am
SNOOKER legend Willie Thorne has been diagnosed with leukaemia. The 66-year-old posted the shock news on Twitter, adding that he is starting chemotherapy in Spain. I realise everybody is having a ...
via Bing News